Results 301 to 310 of about 221,688 (338)
N-actylcysteine inhibits diethyl phthalate-induced inflammation via JNK and STAT pathway in RAW264.7 macrophages. [PDF]
Kim JH, Lee JH, Koo YJ, Song JW.
europepmc +1 more source
The effect of aspirin on aneurysm wall enhancement: A study in rabbits and humans.
Sagues E+11 more
europepmc +1 more source
Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in the human prostate [PDF]
To determine the cell-specific expression of the two major isoforms of cyclooxygenase (COX-1 and COX-2) in human noncancerous and cancerous prostatic tissues.Thirty-one specimens of prostate carcinoma (CaP) and 10 specimens of benign prostatic hyperplasia (BPH) were stained with mouse antihuman COX-1 and COX-2 monoclonal antibodies.
Pamela D. Unger+6 more
openaire +2 more sources
Cyclooxygenase and Colon Cancer [PDF]
There is considerable interest in the involvement of cyclooxygenase-2 (COX-2) in colon carcinogenesis and its progression, because nonsteroidal anti-inflammatory drugs (NSAIDs) reduce mortality from colon cancer and COX-2 is one of the known targets of NSAIDs. COX-2 mRNA and protein levels are increased in colon cancer tissues from patients and in some
Shingo Tsuji+2 more
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
The FASEB Journal, 2001Several studies have demonstrated unequivocally that certain nonsteroidal anti-inflammatory drugs (NSAIDs) such as sodium salicylate, sulindac, ibuprofen, and flurbiprofen cause anti-inflammatory and antiproliferative effects independent of cyclooxygenase activity and prostaglandin synthesis inhibition.
Gerd Geisslinger+2 more
openaire +3 more sources
Pharmacogenomics of Cyclooxygenases
Pharmacogenomics, 2015Cyclooxygenases (COX-1 and COX-2) are key enzymes in several physiopathological processes. Many adverse drugs reactions to NSAIDs are attributable to COX-inhibition. The genes coding for these enzymes (PTGS1 and PTGS2) are highly variable, and variations in these genes may underlie the risk of developing, or the clinical evolution of, several diseases ...
José A. G. Agúndez+3 more
openaire +3 more sources